[Studies on the function of granulopoiesis after cytostatic therapy and bone marrow transfusions].
D000380:Agranulocytosis / Q000209:etiology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016026:Bone Marrow Transplantation; D002277:Carcinoma / Q000628:therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D006410:Hematopoiesis / Q000187:drug effects*; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D008206:Lymphatic Diseases / Q000628:therapy; D010587:Phagocytosis; D055728:Primary Myelofibrosis / Q000628:therapy; D012509:Sarcoma / Q000628:therapy; D013210:Staphylococcus; D013936:Thymidine / Q000378:metabolism; D014182:Transplantation, Autologous; D014228:Triaziquone / Q000627:therapeutic use; D014316:Tritium; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014316:Tritium; D014747:Vinblastine; D003520:Cyclophosphamide; D014228:Triaziquone; D013936:Thymidine
Untersuchungen über die Funktionen der Granulopoese nach zytostatischer Therapie und Knochenmarktransfusionen.